STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

CGC director files Form 3; initial statement shows zero holdings

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Canopy Growth Corp (CGC) reported an insider update: a director filed a Form 3 initial statement of beneficial ownership. The filing states that no securities are beneficially owned as of the event date 10/10/2025.

The submission was filed by one reporting person and includes an Exhibit 24 Power of Attorney authorizing the signatory.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
BAYERN JOSEPH

(Last) (First) (Middle)
C/O CANOPY GROWTH CORPORATION
1 HERSHEY DRIVE

(Street)
SMITHS FALLS A6 K7A 0A8

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/10/2025
3. Issuer Name and Ticker or Trading Symbol
Canopy Growth Corp [ CGC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney.
No securities are beneficially owned.
/s/ Joseph Bayern 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Canopy Growth (CGC) disclose in this Form 3?

A director filed an initial beneficial ownership statement indicating no securities are beneficially owned.

What is the event date in the CGC Form 3?

The event date is 10/10/2025.

Who filed the Form 3 for CGC?

It was filed by one reporting person; the signature line shows /s/ Joseph Bayern under a Power of Attorney.

What is the insider’s relationship to Canopy Growth?

The reporting person is a Director.

Does the Form 3 show any CGC shares owned?

No. The remarks state No securities are beneficially owned.

Does the filing include a Power of Attorney?

Yes. It includes Exhibit 24 - Power of Attorney.
Canopy Growth Corp

NASDAQ:CGC

CGC Rankings

CGC Latest News

CGC Latest SEC Filings

CGC Stock Data

400.37M
341.58M
0.07%
7.26%
6.76%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
SMITH FALLS